Project Grant W81XWH1710678

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will provide $545,612 to The Ohio State University to conduct research aimed at reducing adipose tissue dysfunction and metabolic complications after spinal cord injury (SCI). The key objectives are to evaluate the extent to which modulating the A2D1 subunit of voltage-gated...

This Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), part of the Administration for Community Living, provides $250,000.00 to Baylor Research Institute to conduct a "SCALE-UP EVALUATION TRIAL OF THE DIABETES PREVENTION PROGRAM TO IMPROVE OBESITY AND CARDIOMETABOLIC HEALTH AFTER TRAUMATIC BRAIN INJURY" over the period from Sep 1, 2025 to Aug 31, 2028. The goal of this research project is to evaluate the...

This Project Grant award from the Department of Health and Human Services (HHS) under the National Research Service Awards Health Services Research Training program (CFDA 93.225) will support research at Northwestern University to examine the long-term outcomes and cost implications of inequitable access to acute inpatient rehabilitation for patients with spinal cord injuries (SCI). The $371,024 award will fund a 3-year research project with the following key objectives: 1) characterizing the...

This $631,896 R01 project grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to compare the effectiveness of two remotely-delivered behavioral weight loss interventions. The project will evaluate an automated online program versus a group-based videoconference program, both with and without the addition of individual coaching, to determine which...

This Project Grant award of $111,750.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a study to optimize a weight-neutral intervention to improve health among adults with higher body weight. The study, conducted by The Miriam Hospital, a non-profit hospital in Providence, Rhode Island, will pilot test combinations of evidence-based weight-neutral components,...

This federal Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (CFDA 93.433) provides $400,000 to the Baylor Research Institute to develop a telehealth platform for delivering a weight-loss program tailored for individuals with traumatic brain injury (TBI). The key objectives are to partner with a TBI advisory board to develop the telehealth platform, then pilot the program to assess participant compliance, usability, satisfaction, and...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a 5-year, $663,232 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Florida. The grant will fund a hybrid effectiveness and implementation trial to test the use of online weight loss tools, including a commercial goal-setting and self-monitoring platform and online support communities, to increase weight loss among primary care...

The Medical University of South Carolina (MUSC) received a $1,499,775 Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (CFDA 93.433) to conduct a longitudinal study on opioid use, misuse, and co-use of other substances among individuals with traumatic spinal cord injury (SCI). The 5-year study aims to: (1) describe the prevalence and changes in prescription opioid use, misuse, and co-use of other substances; (2) identify person and...

This Project Grant award of $111,750 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to refine and optimize a telephone-based coaching intervention to help individuals recover from small weight regains during weight loss maintenance. The research team at The Miriam Hospital, a non-profit hospital in Providence, Rhode Island, will use a...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $2,075,497 to The University of Texas Health Science Center at San Antonio to conduct a Phase 4, randomized, double-blind, placebo-controlled clinical study on the glycemic and weight loss effects of the GLP-1 receptor agonist semaglutide in subjects with type 2 diabetes and spinal cord...